Published in J Clin Lab Immunol on June 01, 1987
Studies on the immunosuppressive properties of a pregnancy-associated alpha-macroglobulin. Clin Exp Immunol (1976) 1.45
Preclinical warning of recrudescent mammary cancers by pregnancy-associated alpha-macroglobulin. Br J Surg (1976) 1.30
Synthesis of a pregnancy-associated alpha-macroglobulin by human leucocytes. Experientia (1975) 1.16
An immunoassay for a pregnancy-associated alpha-macroglobulin using antibody-enzyme conjugates. FEBS Lett (1974) 1.15
Oestrogen receptors in macrophages. Scand J Immunol (1990) 1.13
Transplantation--nature's success. Lancet (1972) 1.11
Variations in the serum concentration of a human pregnancy-associated alpha-macroglobulin during pregnancy and after delivery. J Reprod Fertil (1975) 1.07
Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients. Lancet (1975) 1.06
Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines. J Clin Lab Immunol (1987) 1.05
Variations in the level of a pregnancy-associated alpha-macroglobulin in patients with cancer. J Clin Pathol (1975) 1.04
Studies of thyroglobulin autoantibody synthesis using a micro-ELISA assay. Immunol Lett (1982) 1.02
Identification of an immunosuppressive factor in pregnancy serum. Obstet Gynecol (1976) 1.01
Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin. J Clin Lab Immunol (1990) 0.99
Identification of pregnancy-associated alpha-macroglobulin on the surface of peripheral blood leucocyte populations. Clin Exp Immunol (1977) 0.98
A biochemical approach to the staging of human breast cancer. Cancer (1977) 0.98
Oestrogen-induced immunoregulation mediated through the thymus. J Clin Lab Immunol (1980) 0.96
Pregnancy-associated beta 1-macroglobulin: detection on the surface of ovarian cancer cell lines. Int J Cancer (1985) 0.94
Are pregnancy-associated serum proteins responsible for the inhibition of lymphocyte transformation by pregnancy serum? Clin Exp Immunol (1980) 0.92
Effects of steroids on the secretion of immunoregulatory factors by thymic epithelial cell cultures. Immunology (1981) 0.90
Detection of mammary micrometastases by pregnancy-associated alpha 2-glycoprotein (PAG, alpha 2-PAG or PAM) and carcinoembryonic antigen (CEA). Eur J Cancer (1979) 0.90
Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89
Protein markers in disease (2). Pregnancy-associated alpha2-glycoprotein and cancer. J R Coll Surg Edinb (1978) 0.89
The effects of nandrolone, testosterone and their decanoate esters on murine lupus. Clin Exp Immunol (1981) 0.87
The human bladder carcinoma line T-24 secretes a human B-cell differentiation factor. Immunology (1987) 0.87
Letter: Immunosuppressive effect of pregnancy-associated alpha2-macroglobulin. Lancet (1975) 0.86
Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother (1990) 0.86
Studies on the maternal immune response to placental antigens: absence of a blocking factor from the blood of abortion-prone women. Br J Obstet Gynaecol (1979) 0.86
The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. Br J Cancer (1975) 0.85
Comparison of the effects of human pregnancy serum and anti-inflammatory compounds on the release of lysosomal enzymes from macrophages. Br J Exp Pathol (1977) 0.85
M4HS2, a new human T-cell line for the efficient generation of human T-cell hybrids. J Immunol Methods (1986) 0.85
Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer. Eur J Cancer (1997) 0.84
Immunoscintigraphy of metastases with radiolabelled human antibodies. Br Med J (Clin Res Ed) (1987) 0.84
Screening for metastases in breast cancer: an assessment of biochemical and physical methods. Cancer (1981) 0.84
Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann Rheum Dis (1983) 0.83
Effects of adjuvant, dose and carrier pre-sensitisation on the immunisation efficacy of a GnRH analogue. Drug Des Discov (1996) 0.82
Fertility-disrupting potential of synthetic peptides derived from the beta-subunit of follicle-stimulating hormone. Am J Reprod Immunol (1998) 0.81
T-24.B-cell differentiation factor induces immunoglobulin secretion in human B cells without prior cell replication. Immunology (1987) 0.81
Human T-cell hybrids secreting lymphokines: effect of different parent cell clones of the human T-cell acute lymphoblastoid leukaemia line CCRF-CEM. Scand J Immunol (1986) 0.81
Effects of dietary supplementation on autoimmunity in the MRL/lpr mouse: a preliminary investigation. Ann Rheum Dis (1986) 0.80
The molecular weight of pregnancy-associated alpha2-glycoprotein and its subunits. Int J Biochem (1978) 0.80
Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro. Br J Cancer (1989) 0.80
Determination of anti-DNA autoantibody levels in mice by enzyme immunoassay. J Clin Lab Immunol (1984) 0.80
Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury. Mol Cell Biochem (1999) 0.79
Androgen binding cytosol receptors in the rat thymus: physicochemical properties, specificity and localisation. Thymus (1981) 0.79
Rheumatoid factor induction in the mouse: sex differences and the effect of the sex steroids. Immunopharmacology (1990) 0.79
A rapid enzyme immunoassay for the detection of IgM rheumatoid factor--a comparison of "sero-negative" and "sero-positive" rheumatoid patients. J Clin Lab Immunol (1986) 0.79
Investigation into suitable carrier molecules for use in an anti-gonadotrophin releasing hormone vaccine. Vaccine (1998) 0.79
A novel method for boronating antibodies without loss of immunoreactivity, for use in neutron capture therapy. Drug Des Discov (1995) 0.79
Androgen receptor in the human thymus. Immunol Lett (1984) 0.78
Accurate determination of adjuvant-associated protein or peptide by ninhydrin assay. Vaccine (1995) 0.78
A role for amniotic epithelium in control of human parturition. Lancet (1985) 0.78
Studies on the changes in the concentration and total mass of individual serum proteins during late pregnancy. Clin Biochem (1972) 0.78
Generation of human T-cell hybrids with the characteristics of human peripheral blood T-lymphocytes. Immunol Lett (1983) 0.78
Cardiac troponin-I: a biochemical marker for cardiac cell necrosis. Dis Markers (1993) 0.77
The anti-inflammatory profile of dapsone in animal models of inflammation. Agents Actions (1978) 0.77
The in situ expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA at the maternal-fetal interface. Growth Factors (1991) 0.77
Responses of human B-cells to recombinant lymphokines. Dev Biol Stand (1988) 0.77
Monoclonal antibody technology for mycotoxins. Biotechnol Adv (1989) 0.77
The immortalization of human lymphocytes by spheroplast fusion. Dev Biol Stand (1985) 0.77
Detection of ochratoxin A in porcine kidneys by a monoclonal antibody-based radioimmunoassay. Appl Environ Microbiol (1987) 0.76
Determination of ochratoxin A by monoclonal antibody-based enzyme immunoassay. J Assoc Off Anal Chem (1989) 0.76
Proceedings: An investigation into the immunosuppressive properties of oestrogen. J Endocrinol (1976) 0.76
Studies on the anti-inflammatory properties of dapsone in a variety of animal models [proceedings]. Br J Pharmacol (1977) 0.75
The subunits of chemically treated proteoglycan isolated from bovine nasal cartilage. Biochem J (1971) 0.75
Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells. Immunology (1984) 0.75
Letter: Pregnancy-associated alpha2-glycoprotein and cancer. Lancet (1976) 0.75
A comparison of circulating immune complexes, pregnancy associated beta 1-macroglobulin and galactosyltransferase as tumour markers for ovarian cancer. Aust N Z J Obstet Gynaecol (1986) 0.75
Construction of a single-chain Fv from an antibody which catalyses a Diels Alder cycloaddition. Biochem Soc Trans (1996) 0.75
Ability of alpha (but not beta) form interleukin-1 to support DNA synthesis in human tonsillar B cells. Int Arch Allergy Appl Immunol (1989) 0.75
Radiolabelled monoclonal antibodies (McAb): an alternate approach to the conventional methods for the assessment of cardiomyocyte damage in an experimental brain-death pig model. Arch Pharm Res (1998) 0.75
Anti-gonadotropin releasing hormone vaccines and their potential use in the treatment of hormone-responsive cancers. BioDrugs (1999) 0.75
The importance of statistical evaluation and experimental design in the interpretation of data from cancer microdetector studies. Eur J Cancer (1980) 0.75
An investigation into the immunogenicity of a GnRH analogue in male rats: a comparison of the toxicity of various adjuvants used in conjunction with GnRH-glycys. Vaccine (1996) 0.75
Catalytic antibodies: designed and accidental. Biochem Soc Trans (1993) 0.75
The synthesis of low-molecular weight proteoglycans in rabbit-ear cartilage. FEBS Lett (1972) 0.75
Pregnancy-associated alpha 2-glycoprotein. Lancet (1977) 0.75
The evolution of immunoassay technology. Parasitology (1998) 0.75
Complex nature of the human antisperm antibody response in SCID mice. Andrologia (2004) 0.75
Production and characterisation of anti-cardiac troponin-I monoclonal antibodies. Dis Markers (1995) 0.75
Characterization of monoclonal antibodies with specificity for the core oligosaccharide of Shigella lipopolysaccharide. Hybridoma (2001) 0.75
The maternal immune response to a new human trophoblast antigen. J Clin Lab Immunol (1988) 0.75
The value of sequential marker estimations following mastectomy for breast cancer. Eur J Cancer (1980) 0.75
Proceedings: Evidence for immunoregulation by a new thymic hormone during pregnancy. J Endocrinol (1976) 0.75
Pregnancy-associated alpha 2-macroglobulin - a new serum protein elevated in normal human pregnancy. J Reprod Immunol (1983) 0.75
Production and characterization of monoclonal antibodies with diagnostic potential against Shigella flexneri. J Clin Lab Immunol (1989) 0.75
Catalytic antibodies: a new window on protein chemistry. Ciba Found Symp (1991) 0.75
Development of a hormone neutralizing vaccine, using GnRH-glycys-PPD, for use in the treatment of oestrogen-dependent disorders. Ther Immunol (1995) 0.75
The therapeutic effects of dietary fatty acid supplementation in the autoimmune disease of the MRL-mp-lpr/lpr mouse. Int J Immunopharmacol (1988) 0.75
Proceedings: Quantitation of a new serum alpha-macroglobulin in malignant disease, steroid treatment, pregnancy and normal subjects. J Endocrinol (1974) 0.75
Molecular recognition in antibodies and its application. Experientia (1991) 0.75
Immunoscintigraphy of human ovarian cancer xenografts using a radiolabelled monoclonal antibody to human pregnancy serum-derived immune complexes. Nucl Med Commun (1988) 0.75
Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific anti-fertility vaccine for clinical and veterinary use. J Reprod Immunol (2001) 0.75
Exercise induced modulation of immune parameters. Biochem Soc Trans (1995) 0.75
An assay for antigen-antibody complexes in human sera using C1q-enzyme conjugates. J Clin Lab Immunol (1981) 0.75
Pregnancy-associated beta 1-macroglobulin (beta 1-PAM): a new serum protein associated with pregnancy serum-derived immune complexes and ovarian cancer. J Clin Lab Immunol (1981) 0.75
Aflatoxin monoclonals: academic development to commercial production. Lett Appl Microbiol (1990) 0.75
The distribution of pregnancy-associated prostaglandin synthetase inhibitor in the human placenta. J Pathol (1989) 0.75